The Joint Research Laboratory on Advanced Pharma Development together with Ikerbasque invites applications for a Tenure-Track or Tenured Group Leader position in 3D Bioprinting, Tissue Engineering and Regenerative Medicine in the Joint Research Laboratory at the University of the Basque Country UPV/EHU, Spain.
The candidate is expected to establish a leading research program in the areas of 3D bioprinting, micro/nanoscale cell-scaffolding technologies and/or regenerative medicine to develop a range of innovative approaches for tissue and organ regeneration, with a particular focus on personalized medicine involving the use of patient-derived cells to engineer artificial tissues and cell-based therapies.
Potential candidates should have a strong background in vascular, muscular, epithelial tissue engineering, or biomanufacturing of organ-mimicking cellular assembling. Competencies in iPSC-derived organoids and cell reprogramming of patient-derived cells will also be considered.
Additional aspects that will be evaluated are candidate expertise in the physiological functional assessment of artificial tissues, in their three-dimensional morphological characterization, and/or in dealing with bioprinting/microfluidic-based cell-assembly procedures.
The candidate is expected to acquire competitive national and European funding and drive scientific and technical innovation. He/she will work at the interface of multiple research fields while promoting collaborations with international and national research centers. He/she will work as a member of NanoBioCel group, being part of the Joint Research Lab on Advanced Pharma Development initiative.
It is also essential to have outstanding oral and written communication skills and be fluent in English. Knowledge of Spanish and/or Basque will be considered helpful, but it is not compulsory.
This position is funded by the Diputación Foral de Álava and the University of the Basque Country in the campus of Álava and city of Vitoria-Gasteiz. It aims to help to solve major issues in tissue regeneration and repair of defects in a minimally invasive manner using 3D bioprinting technologies working closely with scientists and clinicians.
Candidates should provide:
- A cover letter.
- A research statement outlining the research vision, motivation, and a description of the proposed research to be developed. The statement should explain how the work will fit within the mission of the Joint Research Lab on Advanced Pharma Development initiative and include a brief summary of previous research experiences. Maximum length 2 pages.
- Curriculum Vitae. Maximum length 5 pages.
- Names and contact information of at least three references.
- Applications from women are especially welcome.
For more information, please contact email@example.com
Application deadline: candidates should apply before May 30th. Send your applications to firstname.lastname@example.org
About Joint Research Laboratory on Advanced Pharma Development
The JRL is a joint initiative of the University of the Basque Country UPV/EHU (an ETPN member institution) and Tecnalia supported by Diputacion Foral de Alava to promote research in 3D printing and 3D Bioprinting. The objectives of this initiative include:
- Promote research collaboration in the fundamentals of 3D printing and 3D bioprinting, regenerative medicine and tissue regeneration.
- Increase scientific production by means of high quality scientific journals and intellectual property.
- Explore transfer routes of the intellectual property to the surrounding business network, providing a value chain for the community.
- Select PhD candidates which will become the doctors and professionals in the field.
- Attract financing from public regional and European funds.
About Tecnalia and NanoBioCel group from the University of the Basque Country (UPV/EHU)
NanoBioCel research group in the University of the Basque Country (UPV/EHU) is a Consolidated Group of Excellence type A of the Basque Government and belongs to the CIBER-BBN of the Carlos III Health Institute and to the Unique Scientific and Technical Infrastructure (ICTS) Nanobiosis. NanoBioCel consists of a multidisciplinary group of professors, postdocs and PhD students researching in the fields of Pharmaceutical Science and Tissue Engineering. The laboratory has a wide range of equipment that is directly applicable to this project. For instance, the group has molecular and cellular biology equipment (thermocycler, electrophoresis and Western-Blot equipment, plate readers, chemiluminescent detection systems, flow cytometer, cell culture room), access to animal experimentation facilities, installations for polymer synthesis (argon/nitrogen supply, chemical hoods) and biomaterials fabrication and characterization (rheometer, 3D bioprinter). In addition, the group has access to powerful technological facilities at the University of the Basque Country (SGIKer support platform) and Nanbiosis such as confocal and fluorescent microscopies, scanning electronic microscopy, AFM, NMR, among others.
Tecnalia is the first private applied research center in Spain and the seventh in Europe, with a workforce of 1,405 highly qualified people (229 doctors). Tecnalia is a leading Research and Technological Development Centre in Europe, whose mission is to transform technology into GDP to improve people’s quality of life, by creating business opportunities for companies, being member of BRTA (Basque Research and Technology Alliance). Tecnalia works with an increasingly strategic business relationship model based on trust, collaboration, and a shared technological approach, whereby our main scopes of action are: digital transformation, advanced manufacturing, energy transition, sustainable mobility, health, and the urban ecosystem. The group is the first private Spanish organisation in contracting, participation, and leadership in the European Commission’s Horizon 2020 programme and we are ranked second in European patent applications.
More information about the Basque Country, Alava and city of Vitoria-Gasteiz: